Skip to content

Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate

Comparative Evaluation of New Surgical Robotic Platforms for the Radical Prostatectomy Procedure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05766163
Acronym
COMPAR-P
Enrollment
150
Registered
2023-03-13
Start date
2023-03-14
Completion date
2024-09-30
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Robotic-assisted surgery, Prostatectomy, Multiple surgical platforms, Postoperative complications, Operative outcomes

Brief summary

The object of this exploratory clinical trial is to evaluate post-operative complications in a population that underwent Robotic Assisted Radical Prostatectomy (RARP) made with multiple platforms: * DaVinci; * Hugo; * Versius. The questions it aims to answer are: * Does the estimation of the post-operative complications suggest something? * Are differences (intra-operative, post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to fill out questionnaires and join one of these three groups: 1. surgery with the daVinci platform; 2. surgery with the Hugo platform; 3. surgery with the Versius platform.

Interventions

DEVICEDaVinci RARP

Assisted-robotic radical prostatectomy.

DEVICEHugo RARP

Assisted-robotic radical prostatectomy.

DEVICEVersius RARP

Assisted-robotic radical prostatectomy.

Sponsors

Azienda Ospedaliera Universitaria Integrata Verona
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 and \< 90 years; * Organ-localized prostate cancer with a surgical indication of radical prostatectomy; * Informed consent provided.

Exclusion criteria

* Age \< 18 and \> 90 years; * Contraindication to radical prostatectomy procedure; * Non-organ confined prostate cancer; * Refusal to participate.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with postoperative complicationsOver the 4 days post surgeryOverall postoperative complications (% score \>0) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication
Number of participants with moderate to major postoperative complicationsOver the 4 days post surgeryModerate to major complications (% score \>=2) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication
Number of participants with major postoperative complicationsOver the 4 days post surgeryMajor complications (% score \>=3) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication

Secondary

MeasureTime frameDescription
Number and type of intraoperative complicationsIntraoperativeNote
Postoperative hospitalizationFrom the surgery day up to 10 days postoperativeDays of recovery until the date of release
Postoperative pain1-4 days postoperativeNumerical Rating Scale (NRS) 0-10 scale for the self-reported rate of pain: zero meaning no pain and 10 meaning the worst pain imaginable
Prostate Specific Antigen (PSA)1 month follow-upPSA test
Positive Surgical MarginUp to 2 weeks postoperative (during histological analysis)Rate at histological examination
Estimated Blood LossIntraoperativeVolume
Urinary, sexual, and intestinal function assessmentPreoperative and follow-up (1, 3 and 6 months)University of California, Los Angeles (UCLA) Prostate Cancer Index (PCI) questionnaire Domains: * Urinary function (5 items) * Urinary bother (1 item) * Sexual function (8 items) * Sexual bother (1 item) * Bowel function (4 items) * Bowel bother (1 item) Response options: 3- to 6-point Likert scales. The higher the score, the better the outcome
Quality of Life EvaluationPreoperative and follow-up at 1, 3 and 6 monthsShort Form Health Survey (SF-36) 36 questions (8 domains) for self-reported measure of health. Domain score from 0 to 100: the higher the score, the more favorable the state of health
Time taken for platform-related technical stepsFrom the room setting, through surgical procedure until postoperative room restoration for each of expected 150 surgeries (through study completion: an average of 1 year)Set up of operating table, Electric connections, Draping, Undraping, Docking, Undocking, Cleaning: time in minutes
Possible malfunction of the platformIntraoperativeNote
Procedure-related costsFrom surgical procedure to the end of follow-up period (6 months)Estimate
Lymph nodes resectionIntraoperativeNumber of lymph nodes removed
Overall duration of the surgeryIntraoperativeMinutes
Anesthesia, Lymphadenectomy, ProstatectomyEntrance of patient into operating room until completion of surgeryMinutes

Countries

Italy

Contacts

Primary ContactAlessandro AA Antonelli
alessandro.antonelli@aovr.veneto.it+39 0458127701

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026